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ABSTRACT Following infection of mammalian cells, Salmonella enterica serovar Typhimurium (S. Typhimurium) replicates
within membrane-bound compartments known as Salmonella-containing vacuoles (SCVs). The Salmonella pathogenicity island
2 type III secretion system (SPI-2 T3SS) translocates approximately 30 different effectors across the vacuolar membrane. SseF
and SseG are two such effectors that are required for SCVs to localize close to the Golgi network in infected epithelial cells. In a
yeast two-hybrid assay, SseG and an N-terminal variant of SseF interacted directly with mammalian ACBD3, a multifunctional
cytosolic Golgi network-associated protein. Knockdown of ACBD3 by small interfering RNA (siRNA) reduced epithelial cell
Golgi network association of wild-type bacteria, phenocopying the effect of null mutations of sseG or sseF. Binding of SseF to
ACBD3 in infected cells required the presence of SseG. A single-amino-acid mutant of SseG and a double-amino-acid mutant of
SseF were obtained that did not interact with ACBD3 in Saccharomyces cerevisiae. When either of these was produced together
with the corresponding wild-type effector by Salmonella in infected cells, they enabled SCV-Golgi network association and inter-
acted with ACBD3. However, these properties were lost and bacteria displayed an intracellular replication defect when cells were
infected with Salmonella carrying both mutant genes. Knockdown of ACBD3 resulted in a replication defect of wild-type bacte-
ria but did not further attenuate the growth defect of asseFGmutant strain. We propose a model in which interaction between
SseF and SseG enables both proteins to bind ACBD3, thereby anchoring SCVs at the Golgi network and facilitating bacterial rep-
lication.
IMPORTANCE Upon invasion of epithelial cells, the majority of vacuoles containing Salmonella entericamigrate to the perinu-
clear region-located Golgi network and remain in this region of the cell during the first few rounds of bacterial replication, form-
ing a clustered microcolony of vacuoles. This process requires the action of SseF and SseG, two effector proteins that are translo-
cated by the Salmonella SPI-2 type III secretion system. However, little is known about how they function. Here, we show that
both proteins interact with the mammalian Golgi network-associated protein ACBD3. To our knowledge, the SseF-SseG-ACBD3
interaction is the first example of a tethering complex between a pathogen-containing vacuole and a host cell organelle.
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Salmonella enterica serovar Typhimurium (S. Typhimurium)survives and replicates within a variety ofmammalian host cell
types, including macrophages and epithelial cells. Uptake of bac-
teria by host cells results in the formation of the Salmonella-
containing vacuole (SCV). Acidification and nutritional starva-
tion of the vacuole lumen act as signals for the transcriptional
induction of Salmonella pathogenicity island 2 (SPI-2) type III
secretion system (T3SS) genes (1–4). The type III secretion appa-
ratus assembles in the bacterial cell envelope from approximately
4 to 6 h following bacterial uptake (5, 6). It secretes translocon
proteins that are thought to form a pore in the vacuolar mem-
brane. Sensing of host cell cytosolic pH then dissociates a bacterial
gatekeeper complex, inducing translocation of over 30 different
effector proteins across the vacuolar membrane (5, 7). Effectors
translocated by the SPI-2 T3SS localize to the SCV membrane,
SCV-associated tubules, and the cell cytoplasm, interfering with
normal cell functions and facilitating intracellular bacterial mul-
tiplication (7).
SseF and SseG are SPI-2-encoded effectors that localize to SCV
membranes and SCV-associated tubules called Sifs that are
formed in epithelial cells (8). Both effectors are necessary for the
retention of tightly clustered bacterial microcolonies in close
proximity to the microtubule-organizing center (MTOC) and
Golgi network in epithelial cells (9–14). Intracellular growth and
virulence tests showed that single mutant strains lacking SseF or
SseG have similar levels of attenuation and that a double mutant
lacking both proteins does not have a greater level of attenuation
than the single mutants (12). These results indicate that the two
proteins are involved in the same virulence function. Indeed, SseF
and SseG have been shown to interact following their transloca-
tion into host cells (12), suggesting that formation of het-
erodimers is required to elicit their activity. SseF and SseG share
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approximately 35% similarity at the amino acid level over their
entire lengths and are integral membrane proteins (12, 15). Topo-
logical analyses indicate that the C-terminal region of SseF and
both N- and C-terminal domains of SseG are exposed to the host
cell cytoplasm (9, 11).
Two hypotheses have been proposed to explain the MTOC/
Golgi network localization of SCVs in epithelial cells. One is based
on evidence showing that microtubule motors influence SCV po-
sitioning (10, 11), suggesting that opposing activities of dynein
and kinesin-1 occur on the SCV membrane (16, 17). Under nor-
mal conditions, dynein activity predominates, leading to a rela-
tively stable association of SCVs with Golgi membranes. The sec-
ond hypothesis proposes that SCV positioning is controlled by
physical tethering of SCV membranes to Golgi network-
associated molecules (9, 13). Whatever their precise mecha-
nism(s), SseF and SseG have key functions in regulating SCV lo-
calization: imaging of SCVs in live epithelial cells at approximately
8 h postinvasion revealed that Golgi network-associated vacuoles
containing wild-type bacteria are relatively immobile, whereas
those containing sseG mutant bacteria are highly motile and dis-
play erratic large-scale movements throughout host cells (13).
Close apposition of vacuoles with Golgi membranes could facili-
tate fusion of Golgi network-derived material with SCVs and
thereby provide a source of SCVmembrane or proteins, lipids, or
other molecules that could be exploited by bacteria for nutrition.
To gain further insights into the functions of SseF and SseG, we
carried out a yeast two-hybrid screen and identified ACBD3 as a
host protein interacting with SseG. Further genetic analysis, to-
gether with infection and biochemical assays, showed that SseF,
SseG, and ACBD3 form a trimolecular complex and suggested a
model in which an interaction between SseF and SseG is required
for both effectors to bind ACBD3.
RESULTS
Golgi protein acyl-CoA binding domain containing 3 (ACBD3)
interacts with SseG in Saccharomyces cerevisiae and is required
for SCV-Golgi network association. In an attempt to identify
host cell proteins that interact with SseG, we used pGBT-sseG as a
bait plasmid in a yeast two-hybrid screen with a cDNA library
from HeLa cells. Of 3.6  107 transformants, two grew on syn-
thetically defined quadruple dropout (SD-QDO) medium. DNA
sequencing revealed that they were identical clones encoding res-
idues 188 to 528 of Golgi complex protein 60/Golgi protein acyl
coenzyme A (acyl-CoA) binding domain containing 3 (GCP60/
ACBD3) (here referred to as ACBD3).
The DNA sequence encoding the 188 to 528 residues of
ACBD3 was subcloned to pGAD424 to create plasmid pGAD-
ACBD3188-528. This plasmid supported growth of the yeast strain
carrying pGBT-sseG on SD-QDO (Fig. 1A), indicating that SseG
interacts with ACBD3 in yeast. ACBD3 is a conserved and appar-
ently ubiquitously expressed cytosolic Golgi network-associated
protein of 60 kDa and is composed of several domains: a long
N-terminal acyl-CoA binding domain (ACBD) region, a domain
that is predicted to form coiled-coil interactions, and aC-terminal
Golgi dynamics (GOLD) domain that interacts with giantin,
thereby localizing ACBD3 to Golgi membranes (18).
To investigate the possible involvement of ACBD3 in main-
taining the association between SCVs and the Golgi network, en-
dogenous HeLa cell ACBD3 was depleted by small interfering
RNA (siRNA) (Fig. 1B and D), and these cells were infected with
wild-type S. Typhimurium. Knockdown of ACBD3 by two differ-
ent oligonucleotides resulted in significantly reduced Golgi net-
work association of wild-type bacteria, phenocopying the effect of
mutation in sseG (Fig. 1C and D). This indicates that ACBD3 is
required to maintain the close association between SCVs and the
Golgi network.
SseGS67G does not interact with ACBD3 in yeast but comple-
ments the SCV-Golgi network association defect of an sseGmu-
tant. As an alternative test of the relevance of the SseG-ACBD3
interaction during Salmonella infection, we attempted to obtain a
pointmutant of SseG that fails to interact withACBD3 in yeast. To
do so, a DNA fragment containing sseG flanked by approximately
235 bp of upstream and downstream sequences from pGBT-sseG
was amplified by error-prone PCR and cotransferred with linear-
ized empty bait vector pGBT9 into the yeast reporter strain bear-
ing pGAD-ACBD3188-528. Out of 1,032 transformants that were
screened, 52 were unable to grow on SD-QDO medium. The re-
combinant pGBT9 derivatives were isolated from growth-
defective yeast strains for DNA sequencing. The majority con-
tained nonsense mutations causing premature stop codons, but a
single missense mutation that causes a change of serine 67 to gly-
cine (SseGS67G) was found. This sseGS67G allele was then ligated
into pGBT9, and this was used to verify that SseGS67G did not
interact with ACBD3 in yeast (Fig. 2A).
To analyze the phenotype of the SseGS67G mutant in infected
cells, plasmid psseGS67G was constructed and transformed into
S. Typhimurium carrying a null mutation in sseG. The resulting
strain was used to infect HeLa cells for 14 h, which were then fixed
for immunolabeling of bacteria and giantin, as a marker of the
cis-Golgi network. Therewas no significant difference between the
level of SCV-Golgi network association inHeLa cells infectedwith
this strain (sseG psseGS67G) and that in cells infected with an
sseGmutant carrying the wild-type allele of sseG (sseG psseG):
in both cases, themajority of SCVswere found in close association
with the Golgi network (Fig. 2B). However, the presence of
psseGS67G in a sseFG mutant failed to complement the Golgi
network association defect of the double mutant strain (Fig. 2B),
indicating that SseGS67G requires SseF for its function. These re-
sults show that lack of interaction between SseGS67G and ACBD3
in yeast does not prevent SCVs from associating with the Golgi
network. This suggests that ACBD3might not be a physiologically
relevant host cell binding partner of SseG. Alternatively, since
SseG interacts with SseF and the Golgi network association phe-
notype of S. Typhimurium also requires SseF (12), it is possible
that ACBD3 also interacts with SseF (or other effectors) in the
presence of SseGS67G, to maintain SCV-Golgi network associa-
tion.
SseF1-166 interacts with ACBD3 in yeast, and simultaneous
disruption of SseF-ACBD3 and SseG-ACBD3 interactions re-
sults in reduced association of SCVs with the Golgi network.
Next, we determined if SseF interacts with ACBD3 in yeast. As
full-length SseF (amino acids 1 to 260) fused to the GAL4 DNA-
binding domain (GBD::SseF) was toxic to yeast cells (results not
shown), plasmids pGBT-sseF1-166 and pGBT-sseF105-260 were con-
structed and the encoded truncated proteins were tested for their
ability to bind ACBD3. The yeast reporter strain carrying pGAD-
ACBD3188-528 grew on SD-QDOmedium when transformed with
pGBT-sseF1-166 but not with pGBT-sseF105-260 (Fig. 3A), indicat-
ing that the N-terminal 166 amino acids of SseF are sufficient to
interact with ACBD3 in this assay.
Yu et al.
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To isolate a mutation of SseF1-166 that prevents interaction
with ACBD3, a screen was carried out using variants of SseF1-166
generated by error-prone PCR in yeast cells containing pGAD-
ACBD3188-528, as described above for sseG. Out of 1,670 transfor-
mants that were screened, 58 were unable to grow on SD-QDO
medium. Of these, the minimally perturbed mutant that failed to
support growth of the yeast reporter strain carried two amino acid
substitutions (SseF1-166C109W,D129G) (Fig. 3A). To test the effect of
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FIG 1 ACBD3 interacts with SseG and is required for the Golgi network association of SCVs. (A) Growth of S. cerevisiae PJ69-4A transformants on SD-DDO
(SD/-Leu-Trp dropout supplement) and SD-QDO (SD/-Leu-Trp-His-Ade dropout supplement) plates. 1, pGBT-sseG pGAD-cDNA1 (prey plasmid isolated
from original yeast two-hybrid screening); 2, pGBT-sseG  pGADT7-T (vector used for constructing HeLa cell cDNA library); 3, pGBT-sseG  pGAD-
ACBD3188-528 (cDNA encoding ACBD3188-528 ligated into pGAD424). (B to D) Knockdown of ACBD3 by siRNA affects the Golgi network association of SCVs.
HeLa cells were treated with scramble siRNA or ACBD3 siRNAs (oligonucleotide 30161 or 185515) for 72 h and then collected for immunoblotting to check
knockdown of ACBD3 (B) or reseeded for infection with S. Typhimurium expressing GFP. Fourteen hours after infection, cells were fixed with PFA and labeled
for giantin (red) and ACBD3 (blue) for Golgi network association scoring (C) and confocal microscopemicrographs (D). (C) Data represent means standard
errors of the means (SEM) from three independent experiments. The infected cells treated with oligonucleotide 30161 or 185515 were compared with infected
cells treated with scramble oligonucleotide. **, P 0.01; ***, P 0.001. (D) Bars, 5 m. wt, wild type.
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the double substitution mutant on SCV-Golgi network associa-
tion, plasmid psseFC109W,D129G was constructed (encoding full-
length SseFwith two substitutions) and transformed into an sseFG
double mutant carrying psseG. HeLa cells were infected with the
sseFG psseFC109W,D129G psseG strain for 14 h and then fixed for
immunolabeling of Salmonella and the Golgi network. There was
no significant difference between the level of SCV-Golgi network
association in HeLa cells infected with this strain and that in cells
infectedwith thewild-type strain orwith the doublemutant strain
carrying the wild-type sseF allele and psseGS67G. In each case, the
majority of SCVs were found in close association with the Golgi
network (Fig. 3B and C), indicating that, as for the SseG single
substitution, disrupting the SseF-ACBD3 interaction in yeast does
not prevent SCVs from associating with the Golgi network.
It remained possible that, in infected HeLa cells, both SseF and
SseG interact with ACBD3 and that the wild-type form of one
Salmonella protein is sufficient to mediate SCV-Golgi network
association in the presence of the single or double point mutant
version of the other (i.e., in sseFG psseFC109W,D129G  psseG
strain-infected HeLa cells, SseG interacts with ACBD3 to mediate
Golgi network association, and in sseG psseGS67G strain-infected
HeLa cells, SseF interacts with ACBD3 to mediate Golgi network
association). Therefore, to test if simultaneous disruption of the
SseG-ACBD3 and SseF-ACBD3 interactions that occur in yeast
impairs SCV-Golgi network association, psseGS67G and
psseFC109W,D129G were cotransformed into the sseFG double null
mutant, and this strainwas used to infectHeLa cells. In contrast to
the expression of the point mutants of either SseF or SseG, this
strain was unable to complement the Golgi network association
defect of the sseFG mutant (Fig. 3B and C). Therefore, these
results show that, when expressed from Salmonella, the single and
double point mutant versions of SseG and SseF are functional in
the presence of the wild type but not the point mutant version of
the other protein. Since these point mutants have lost their ability
to interact individually with ACBD3 in yeast, the results suggest
that in infected cells, SseF and SseG might form a complex with
ACBD3 that is required to maintain the association of SCVs with
the Golgi network.
SseFandSseG interactwithACBD3 in infectedHeLacells.To
determine if interaction between ACBD3 and SseF occurs in in-
fected cells, HeLa cells were infected for 14 h with either sseF or
sseFGmutant strains expressing epitope-tagged SseF-2HA from
psseF-2HA. Cells were lysed and subjected to immunoprecipita-
tion with antihemagglutinin (anti-HA) antibody-conjugated
beads. In sseF psseF-2HA strain-infected cells (in which the ma-
jority of SCVs were Golgi network associated), ACBD3was repro-
ducibly coimmunoprecipitated with SseF-2HA (Fig. 4A). How-
ever, ACBD3was not coimmunoprecipitated by SseF-2HA in cells
infected with thesseFG psseF-2HA strain (Fig. 4A). This demon-
strates that SseF interacts with ACBD3 in infected HeLa cells and
that this interaction depends on the presence of SseG.
Next, we tested the ability of translocated SseGS67G and
SseFC109W,D129G to interact with ACBD3 in epithelial cells. For
this, we constructed plasmids psseF sseG-Flag, psseFC109W,D129G
sseGS67G-Flag, psseF sseGS67G-Flag, and psseFC109W,D129G sseG-
Flag, in which expression of SseF and SseG or their variants is
under the control of their endogenous sseA promoter. Plasmids
were transformed into the sseFG mutant, and the resulting
strains were used to infect HeLa cells for 14 h. Cell lysates were
incubated with anti-Flag antibody-conjugated beads to immuno-
precipitate Flag-tagged SseG or SseGS67G. ACBD3 was reproduc-
ibly coimmunoprecipitatedwith SseG-Flag or SseGS67G-Flag from
cells infected with sseFG psseFsseG-Flag, sseFG psseFsseGS67G-
Flag, orsseFG psseFC109W,D129G sseG-Flag strains (Fig. 4B). How-
ever, ACBD3 was not coimmunoprecipitated with SseGS67G-Flag
from cells infected with the sseFG psseFC109W,D129G sseGS67G-
Flag strain, despite efficient immunoprecipitation of SseGS67G-
Flag. These results demonstrate that the ability of SseG to interact
with ACBD3 inHeLa cells is prevented only by concurrent expres-
sion of SseF and SseGmutants that do not interact with ACBD3 in
yeast. The results are also consistent with the conditional func-
tionality of the single and double point mutant versions of SseG
and SseF with respect to Golgi network localization in infected
HeLa cells (Fig. 3B). Taken together with the effect of depletion of
ACBD3 on Golgi network localization of SCVs, our results indi-
cate that an interaction between SseF, SseG, and ACBD3 is re-
quired to maintain the association between SCVs and the epithe-
lial cell Golgi network.
Interactions with ACBD3 facilitate intracellular bacterial
replication. To analyze the importance of interactions between
SseF, SseG, and ACBD3 in Salmonella replication in epithelial
cells, HeLa cells were infected with different Salmonella strains for
2 h or 9 h and then fixed and labeled with anti-Salmonella anti-
body to enumerate intracellular bacteria by microscopy. At 2 h
postuptake, intracellular bacterial numbers were similar in cells
infected with different strains (Fig. 5A). At 9 h postuptake, ap-
proximately 54% of cells infected with the sseFG psseFsseG-Flag
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FIG 2 SseGS67G does not interact with ACBD3 but complements the sseG
mutant for association with the Golgi network. (A) Growth of S. cerevisiae
PJ69-4A transformants on SD-DDO and SD-QDO plates. 1, pGBT-sseG 
pGAD-ACBD3188-528; 2, pGBT-sseGS67G pGAD-ACBD3188-528. (B) SseGS67G
complements the sseG mutant but not the sseFG mutant for association with
the Golgi network. HeLa cells were infected for 14 h with indicated strains,
fixed, and immunolabeled to detect Salmonella and giantin for Golgi network
association scoring. Data represent means  SEMs from three independent
experiments. Cells infected with the wild-type (wt) strain were compared with
cells infected by other indicated strains. ***, P 0.001; NS, not significant.
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strain had more than 16 bacteria, a level which was similar to that
of wild-type-infected cells. However, only approximately 14% of
cells infected with the sseFG psseFC109W,D129G sseGS67G-Flag
strain had more than 16 bacteria, similar to the sseFG pWSK29
strain-infected cells (Fig. 5A). This demonstrates that when com-
bined, the presence of single and double pointmutants of sseG and
sseF causes a replication defect in infected cells. Since these mu-
tants also disrupt the interactionwith ACBD3 (Fig. 4B), these data
provide correlative evidence that interactions between SseF, SseG,
and ACBD3 are required for bacterial replication in epithelial
cells.
Next, we investigated the effect of depletion of ACBD3 on bac-
terial growth in HeLa cells. ACBD3 was depleted from HeLa cells
using one of two different siRNA oligonucleotides prior to infec-
tion with wild-type green fluorescent protein (GFP)-expressing
S. Typhimurium for 2 h or 9 h. Cells were fixed and examined by
microscopy, as described above. At 2 h postuptake, there were 1 or
2 bacteria in approximately 80% of infected cells pretreated with
scramble siRNA or ACBD3 siRNA. By 9 h postuptake, approxi-
mately 53% of infected cells pretreated with scramble siRNA had
more than 16 bacteria, but approximately 30% of infected cells
pretreated with either of the two ACBD3-targeting siRNAs had
more than 16 bacteria (Fig. 5B). This demonstrates that depletion
of ACBD3 inhibits bacterial replication.
To determine if the growth advantage conferred by SseF and
SseG is dependent on ACBD3, the intracellular growth of the
sseFGdoublemutant strainwasmeasured following depletion of
ACBD3. HeLa cells were pretreated with scramble or ACBD3-
specific siRNAs and then infected with thesseFG double mutant
strain expressing GFP. At 2 h postinvasion, there was no detect-
able difference between numbers of sseFG mutant bacteria in
scramble- or ACBD3-depleted cells (Fig. 5C). At 9 h postinvasion,
the numbers of sseFGmutant bacteria in ACBD3-depleted cells
were indistinguishable from those of the samemutant in ACBD3-
replete cells (Fig. 5C). Therefore, loss of SseF, SseG, or ACBD3 all
leads to an intracellular growth defect, but absence of ACBD3does
not further attenuate the growth defect of the sseFG mutant
strain. This provides direct evidence that the replicative capacity
mediated by SseF and SseG requires the presence of ACBD3.
DISCUSSION
Upon invasion of epithelial cells, the majority of SCVs migrate to
the perinuclear region-located MTOC and Golgi network and re-
main in this region of the cell during the first few rounds of bac-
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with the Golgi network. (A) Growth of S. cerevisiae PJ69-4A transformants on SD-DDO and SD-QDO plates. 1, pGBT-sseF1-166  pGAD-ACBD3188-528; 2,
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carrying the indicated plasmids. HeLa cells were infected for 14 h with indicated strains, fixed, and immunolabeled to detect Salmonella and giantin. Data
represent means  SEMs from three independent experiments. Cells infected with the wild-type strain were used for comparison with cells infected by other
indicated strains. ***, P 0.001; NS, not significant. (C) Representativemicrographs taken from the experiment in panel B. Green, Salmonella; red, giantin. Bars,
5 m.
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terial replication, forming a clustered microcolony of SCVs. Bac-
terial strains carrying mutations in sseF or sseG move to the
MTOC/Golgi network with kinetics similar to those of wild-type
bacteria but fail to form stable microcolonies. Instead, their SCVs
move erratically throughout the cytoplasm of infected cells, re-
sulting in a scattered phenotype (9, 12, 13). This phenotype sug-
gests that SseF and SseG function by tethering SCVs to a Golgi
network-associated compartment and/or by modulating the ac-
tivities of microtubule motors, which are known to interact with
SCVs (10, 11, 14, 19, 20), in a way that favors minus-end-directed
dynein activity on SCVs.
Within SPI-2, sseF and sseG are located in the same operon as
genes encoding translocon components of the T3SS (21) and, un-
like several effectors, appear to be functional in all serovars of
S. enterica (22). This suggests that they were acquired early in the
development of the effector repertoire of this T3SS and that their
functions are important for bacterial virulence in different mam-
malian hosts. In this study, we have gained more insight into SseF
and SseG and how they might function to localize SCVs at the
Golgi network. A yeast two-hybrid screen with SseG and cDNAs
from HeLa cells led to the identification of ACBD3 as an SseG-
interacting protein. That ACDB3 might be a bona fide binding
partner was suggested by its cytoplasmic Golgi network-
associated location, interaction with the Golgi network-tethering
protein giantin (18), and the scattered distribution of SCVs con-
taining wild-type bacteria in epithelial cells that had been depleted
of ACBD3. However, in view of the high rate of false-positive hits
that can result from screens of this type, we sought additional
evidence for the physiological significance of SseG-ACBD3 inter-
actions by assessing the functionality of a minimally altered SseG
mutant that failed to interact with ACBD3 in yeast. A single-
amino-acid variant that did not interact with ACBD3 in yeast was
obtained, but this was functional in terms of its ability to rescue
the Golgi network association defect of an S. Typhimurium sseG
null mutant. Yeast two-hybrid assays also established ACBD3 as a
potential protein interacting with SseF, and in this case, a double-
amino-acid variant of SseF that lost the interactionwithACBD3 in
yeast also retained the ability to complement an S. Typhimurium
sseF null mutant for Golgi network localization. However, when
the mutant versions of SseF and SseG were combined in the same
bacterial strain, these failed to complement the Golgi network
association and intracellular growth defects of the double null
mutant. The ability of SseG to immunoprecipitate ACBD3 in in-
fected cells was also lost if both SseF and SseGwere present in their
mutant forms, but SseG-ACBD3 binding was retained if either the
SseF or SseG variant was coexpressed with the corresponding
wild-type protein. Furthermore, knockdown of ACBD3 reduced
growth of intracellular wild-type Salmonella but did not exacer-
bate the growth defect of the sseFG mutant strain. Together,
these experiments provide strong evidence that the functionality
of pointmutant forms of SseF or SseG is dependent on awild-type
version of the corresponding protein and that they interact with
ACBD3 to mediate Golgi network association of SCVs and bacte-
rial replication in epithelial cells.
Both SseF and SseG are integral membrane proteins that form
heterodimers (12, 15). Topological experiments have revealed
that the N and C termini of both proteins are exposed to the
cytoplasm (9, 11) (see also Fig. S1 in the supplemental material).
The evidence presented here is consistent with a model (Fig. 6) in
which the S67G point mutation in SseG localizes within or at the
cytoplasmic interface of the first transmembrane region. In SseF,
one mutation (C109W) is located near the cytoplasmic face of the
second transmembrane region, and the other (D129G) lies in the
C-terminal region exposed to the cytoplasm. In cells infected with
strains expressing either SseF or SseG, we propose that the bacte-
rial effector is held in a closed or autoinhibited conformation that
does not allow its interaction with ACBD3 (Fig. 6A). In the yeast
two-hybrid assay, it is possible that fusion of the GAL4 DNA-
binding domain to SseG disrupts its autoinhibited state, enabling
it to bind ACBD3. In our model, the point mutations affect the
correct folding of the cytoplasmic regions and disrupt the binding
interfaces between effectors and ACBD3. Simultaneous produc-
tion of both wild-type effectors by intracellular bacteria leads to
their heterodimerization, possibly via their C-terminal domains,
and this exposes the regions of SseF and SseG that interact with
ACBD3 (Fig. 6B). Thus, although SseF or SseG point mutants fail
to bind ACBD3 either in yeast or in infected cells, if the corre-
sponding protein is present in its wild-type form, the formation
of a heterodimer exposes a functional ACDB3 binding region,
which would account for the conditional phenotype of the
point mutants (Fig. 6C and D). Production of SseF and SseG
mutants from the same bacterial cell does not allow either pro-
tein to interact with ACBD3, and this, or the absence of
ACBD3, causes a loss of tethering and Golgi network associa-
tion (Fig. 6E and F). Attempts to test this model experimentally
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FIG 4 Coimmunoprecipitation assays. (A) SseG is required for SseF to inter-
act with ACBD3 in infectedHeLa cells. HeLa cells were infected with indicated
bacterial strains for 14 h and then lysed to immunoprecipitate SseF-2HA.
Samples were separated by SDS-PAGE for immunoblotting. (B)
SseFC109W,D129G and SseGS67G fail to interact with ACBD3. HeLa cells were
infected with the sseFG mutant expressing Flag-tagged SseG or SseGS67G and
untagged SseF or SseFC109W,D129G for 14 h. Cell lysates were prepared to im-
munoprecipitate SseG-Flag or SseGS67G-Flag. Samples were separated by SDS-
PAGE for immunoblotting.
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FIG5 Interaction of ACBD3with SseF and SseG facilitates Salmonella replication inHeLa cells. (A) SseFC109W,D129G and SseGS67G fail to rescue the sseFGmutant
for replication in HeLa cells. HeLa cells were infected with indicated bacterial strains for 2 h or 9 h and then fixed with PFA and labeled for Salmonella before the
number of bacteria in infected cells was quantified bymicroscopy. Cells infected with the sseFGmutant or with the sseFGmutant carrying the indicated plasmids
were compared with cells infected with the wild-type (wt) strain at corresponding time points. Data represent means  SEMs from three independent
experiments. ***,P 0.001;NS, not significant. (B)KnockdownofACBD3 impairs replication ofwild-type Salmonella inHeLa cells.HeLa cells were treatedwith
scramble siRNAor ACBD3 siRNAs (oligonucleotide 30161 or 185515) for 72 h and reseeded for infectionwith wild-type S. Typhimurium expressingGFP. At 2 h
or 9 h after infection, cells were fixed with PFA and the numbers of bacteria in infected cells were quantified by microscopy. The oligonucleotide 30161- or
185515-treated cells were compared with scramble oligonucleotide-treated cells at corresponding time points. Data represent means  SEMs from three
independent experiments. **, P 0.01; ***, P 0.001. (C) Knockdown of ACBD3 does not further attenuate the replication defect of the sseFGmutant in HeLa
cells. HeLa cells were treated with scramble siRNA or ACBD3 siRNAs (oligonucleotide 30161 or 185515) for 72 h and reseeded for infection with the sseFGmu-
tant expressing GFP. At 2 h or 9 h after infection, cells were fixed with PFA and the numbers of bacteria in infected cells were quantified by microscopy. The
oligonucleotide 30161- or 185515-treated cells were compared with scramble oligonucleotide-treated cells at corresponding time points. Data represent
means SEMs from three independent experiments. NS, not significant. PI, postinvasion.
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have been hampered by the instability of the truncated forms of
both proteins (results not shown). A detailed mechanistic un-
derstanding of the interactions between SseF, SseG, and
ACBD3 now requires knowledge of the three-dimensional
structures of the effectors in isolation, as heterodimers, and
when bound to ACBD3.
Correct positioning of eukaryotic organelles is essential for the
normal processes of cell function and division. Several tethering
complexes that ensure stable associations and close proximity of
opposing organelle membranes have been identified. These in-
clude complexes connecting mitochondria and the endoplasmic
reticulum (ER), peroxisomes, and autophagosomes, as well as
complexes between the ER and plasmamembrane. These interac-
tions often involve high-affinity lipid binding domains and inte-
gral membrane proteins (23) that form a physical bridge between
the two organelles. The contact sites do not usually fuse but facil-
itate interorganelle signaling, ion transport, and nonvesicular
lipid exchange across the twomembranes (24, 25). To our knowl-
edge, the SseF-SseG-ACBD3 interaction is the first example of a
tethering complex between a pathogen-containing vacuole and
host cell organelles. Stable and close apposition between SCV and
Golgi membranes might enable Salmonella to recruit Golgi
network-derived proteins or lipids such as cholesterol, some of
which is transported through the Golgi network and accumulates
in the SCV membrane (26, 27). Another possibility is that phos-
phoinositide 4-phosphate [PI(4)P] present in the SCVmembrane
(28) is generated by the activity of phosphatidylinositol 4-kinase
III, a binding partner of ACBD3 (29). However, using the
PI(4)P-binding domain of Legionella pneumophila SidC as a probe
to visualize SCV-associated PI(4)P (28), we were unable to detect
obvious differences in labeling between SCVs containing wild-
type and sseFG mutant bacteria (results not shown). Alterna-
tively, the significance of the interaction between SseF, SseG, and
ACBD3might be indirect, by retaining SCVs at a cellular location
where they aremore likely to encounter Golgi network-derived or
endosomal tubules or vesicles with which they could fuse. What-
ever the precise consequences of the SseF-SseG-ACBD3 interac-
tion, our growth assays (Fig. 5) indicate that it is important for
efficient replication of vacuolated Salmonella within epithelial
cells.
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FIG 6 Model of interaction between ACBD3 and SseF and SseG. (A) ACBD3 (blue) interacts with the integral membrane protein giantin (red) at the Golgi
network. In the absence of SseG, SseF assumes a closed conformation and is unable to interact with ACBD3. (B) When both SseG and SseF are present, they
interact. This changes their conformations to allow them to interact with ACBD3. (C) A point mutant of SseG (SseGS67G) is unable to interact with ACBD3 but
remains functional by enabling SseF to interact with ACBD3. (D) A double mutant of SseF (SseFC109W,D129G) is unable to interact with ACBD3 but remains
functional by enabling SseG to interact with ACBD3. (E) Simultaneous disruption of SseF-ACBD3 and SseG-ACBD3 interactions by coexpression of mutant
forms of both SseF and SseG prevents SCVs from stable association with the Golgi network. (F) Depletion of ACBD3 prevents SCVs from associating with the
Golgi network.
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MATERIALS AND METHODS
Bacterial strains and growth conditions. Salmonella enterica serovar Ty-
phimurium wild-type strain NCTC 12023 and its isogenic mutant deriv-
ative sseF::aphT (sseF) and sseG::aphT (sseG) (21) and sseFG (12)
strains were used in this study. Bacteria were grown in Luria-Bertani (LB)
medium supplemented with ampicillin (50 g ml1) and/or chloram-
phenicol (34 g ml1) for plasmid-containing strains as appropriate.
Construction of plasmids. Primers (sequences of primers used in this
study are listed in Table S1 in the supplemental material) sseGyf and
sseGyr, sseFyf and sseF166yr, or sseF105yf and sseFyr were used to amplify
sseG, sseF1-166, and sseF105-260 by PCR from S. enterica serovar Typhimu-
rium strain 12023 genomic DNA. The PCR products were digested with
EcoRI and XhoI and ligated into the EcoRI and SalI sites of pGBT9 to
create pGBT-sseG, pGBT-sseF1-166, and pGBT-sseF105-260 for the yeast
two-hybrid assay. Plasmid pGAD-cDNA1 (see below) was used as the
template to amplify DNA sequence encoding ACBD3188-528 with primers
ACBD3188f and ACBD3528r, and the PCR product was digested with
EcoRI and XhoI and ligated into the EcoRI and SalI sites of pGAD424 to
construct pGAD-ACBD3188-528.
Primers sseGS67Gf and sseGS67Grwere used for reverse PCRby using
psseG (21) as the template to introduce the S67G point mutation of sseG
into complementing plasmid psseGS67G. To create psseFC109W,D129G, over-
lapping PCRwas carried out. In the first round of PCR, primers sseF1 and
sseF2 were used to amplify sseF1-166C109W,D129G from pGBT-sseF1-
166C109W,D129G, and primers sseF3 and sseF4 were used for sseF161-260 from
Salmonella genomic DNA. In the second round of PCR, the mixture of
purified PCR products sseF1-166C109W,D129G and sseF161-260was used as the
template to amplify sseFC109W,D129G by using primers sseF1 and sseF4. The
resulting PCR product was digested with EcoRV and SacI and used to
replace sseF-2HA of psseF-2HA (5) to create psseFC109W,D129G.
To coexpress sseF and sseG-Flag or their variants under the control of
their native sseA promoter from a low-copy-number plasmid, pWSK29
(30), the corresponding DNA fragments were amplified by PCR as the
following: primers sseF1 and sseF5 for sseF by using strain 12023 genomic
DNA as the template and sseFC109W,D129G by using plasmid
psseFC109W,D129G as the template and primers sseG1 and sseGflagr for sseG
by using 12023 genomic DNA as the template and sseGS67G by using plas-
mid psseGS67G as the template. DNA fragments of sseF or sseFC109W,D129G
were digested with EcoRV and BamHI, and fragments of sseG or sseGS67G
were digestedwith BamHI and SacI. Plasmid psseF-2HAwas digestedwith
EcoRVand SacI to remove insert sseF-2HA, and a pWSK29-sseApromoter
fragment recovered froman agarose gelwas used for ligationwith digested
sseF or sseFC109W,D129G and sseG or sseGS67G to create psseF sseG-Flag,
psseFC109W,D129G sseGS67G-Flag, psseF sseGS67G-Flag, and psseFC109W,D129G
sseG-Flag.
All the plasmids constructed in this study were verified by DNA se-
quencing.
Yeast two-hybrid assay. pGBT-sseG was used as a bait plasmid to
screen a cDNA library from HeLa cells (pretransformed human HeLa
Matchmaker cDNA library; DB Biosciences; catalog no. HY4027AH) ac-
cording to the manufacturer’s instructions. Of 3.6  107 transformants,
two grew on SD-QDO stringent selective medium (SD/-Leu-Trp-His-
Ade dropout supplement). Plasmids were prepared from the yeast strain
and transformed into Escherichia coli KC8, and transformation mixtures
were plated onto M9 medium with leucine dropout supplement to select
and isolate the prey plasmid (named pGAD-cDNA1 and -2) for DNA
sequencing.
For the randommutagenesis screens, primers GBT641 andGBT1134r
were used to amplify sseGor sseF1-166 and its 235-bpflanking fragments on
vector from bait plasmid pGBT-sseG or pGBT-sseF1-166 by using the Gen-
eMorph random mutagenesis kit (Stratagene; catalog no. 600550). The
PCRproduct and empty bait vector pGBT9 linearizedwith EcoRI andPstI
were cotransferred into the Saccharomyces cerevisiae PJ69-4A strain car-
rying prey plasmid pGAD-ACBD3188-528 and plated onto SD-DDO (SD/-
Leu-Trp dropout supplement) plates to select transformants. The trans-
formants were then tested for their inability to grow on SD-QDO
medium. Plasmids from transformants failing to grow on SD-QDO me-
diumwere isolated and transformed into E. coliKC8, and the transforma-
tionmixturewas plated ontoM9plates suppliedwith tryptophan dropout
supplement to select and isolate the bait plasmid for DNA sequencing.
Only a missense mutation(s) in sseG or sseF1-166 was subcloned onto
pGBT9 to verify its inability to interact with ACBD3 in a yeast two-hybrid
assay.
Antibodies. The following primary antibodies were used for immu-
nofluorescence labeling or immunoblotting: mouse anti-ACBD3 (Sigma)
at a 1:1,000 dilution for immunofluorescence labeling and a 1:3,000 dilu-
tion for immunoblotting; mouse anti-glyceraldehyde-3-phosphate dehy-
drogenase (anti-GAPDH) (Abcam) at a 1:1,000 dilution and mouse anti-
Flag (M2; Sigma) at a 1:2,000 dilution for immunoblotting; rabbit
antigiantin (Covance) at a 1:1,000 dilution, rabbit anti-TGN46 (LifeSpan
Biosciences) at a 1:500 dilution, and goat anti-Salmonella antibody
(CSA-1; Kirkegaard & Perry Laboratories) at a 1:200 dilution for immu-
nofluorescence labeling; and mouse anti-HA (HA.11; Covance) at a
1:5,000 dilution for immunoblotting and a 1:1,000 dilution for immuno-
fluorescence labeling.
Rhodamine Red X-conjugated donkey anti-mouse or anti-rabbit an-
tibody, donkey anti-goat or donkey anti-rabbit–cyanine 2 (Cy2) anti-
body, and Cy5-conjugated donkey anti-mouse antibody were purchased
from Jackson ImmunoResearch Laboratories, Inc. (West Grove, PA), for
immunofluorescence labeling. Horseradish peroxidase (HRP)-
conjugated goat anti-rabbit and goat anti-mouse antibodies were pur-
chased from Dako for immunoblotting.
Cell culture, siRNA transfection, and bacterial infection. The HeLa
(cloneHtTA1) cell linewas obtained from the EuropeanCollection ofCell
Cultures. Cells were maintained in Dulbecco’s modified Eagle’s medium
(DMEM) supplemented with 10% fetal bovine serum (Sigma) at 37°C in
a humidified atmosphere containing 5% (vol/vol) CO2. HeLa cells were
treated twice with duplex RNA oligonucleotides to knock down ACBD3
as described previously (31). ACBD3 was targeted with the oligonucleo-
tides 30161 (GGUUGGAUUCUUUGAUGUGTT) or 185515 (AUUGAU
GGCUGCCAGCAUACACCUC). The scrambled sequence (AAACUUG
UCGACGAGAAGCAAUU) was used as a control.
For bacterial infection, HeLa cells were seeded at a density of approx-
imately 5 104 cells per well in 24-well microtiter plates 16 to 20 h before
infection. Infection with S. Typhimurium was done as described previ-
ously (32).
Immunofluorescence microscopy. Cells were fixed, permeabilized,
and incubated with antibodies as described previously (32). Labeled cells
were analyzed by using a fluorescence microscope (BX50; Olympus) or a
laser scanning confocal microscope (LSM510; Carl Zeiss). Quantification
of the number of bacteria associated with the Golgi network was carried
out as described previously (9). At least 100 infected cells were scored
blind in each experiment. The images were processed using Adobe Pho-
toshop.
A simplified scoring system, in which bacterial numbers were binned
into two groups at 2 h postuptake (1 to 2 bacteria/cell or 3 to 5 bacteria/
cell) and 9 h postuptake (15 bacteria/cell or16 bacteria/cell), was used
to measure intracellular bacterial growth bymicroscopy. Assessing bacte-
rial replication in this way is more tedious than counting bacterial CFU
following host cell lysis but can provide a more accurate estimation of net
intracellular growth if, for example, the bacterial strains induce different
levels of host cell lysis.
Coimmunoprecipitation.HeLa cells grown in 150-mmdishes (Corn-
ing, United Kingdom) were infected with S. Typhimurium for 14 h.
Phosphate-buffered saline (PBS)-washed cells were scraped with a rubber
policeman, centrifuged for 5min at 100 g, and resuspended in 500l of
lysis buffer (PBS–5% glycerol–0.5% Triton X-100–1 mM phenylmethyl-
sulfonyl fluoride [PMSF]) for 30 min at 4°C. Lysates were centrifuged for
10 min at 16,000 g to remove debris before being precleaned with 20l
of proteinG agarose for 1 h (Pierce). The precleaned lysatewasmixedwith
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40 l of anti-HA antibody-conjugated agarose (Pierce) or anti-Flag
antibody-conjugated M2 agarose (Sigma) and incubated at 4°C for 2 h to
immunoprecipitate HA-tagged SseF or Flag-tagged SseG. The immuno-
precipitates were washed 4 times with lysis buffer and then eluted with
50 l of 2 mg/ml HA peptide or 0.1 mg/ml Flag peptide. Sample proteins
were separated by SDS-PAGE and analyzed by immunoblotting with ap-
propriate antibodies.
Topological analysis of SseF. HeLa cells were transfected with
0.2g/ml plasmid pCMVHA-sseF (12) for 16 h byusing the jetPEI reagent
(Qbiogene), as detailed by the manufacturer. Cells were permeabilized
with 25g/ml digitonin (Sigma) for 5min on ice (33) and then fixed with
3%paraformaldehyde (PFA) before immunolabeling. The fixed cells were
labeled with antibodies in the absence of detergent or in the presence of
0.1% Triton X-100 as a positive control.
Statistical analysis.All graphs show themean the standard error of
the mean (SEM) for three independent experiments. Statistical analyses
were performed with Prism 5 software (GraphPad) using one-way analy-
sis of variance (ANOVA) and Dunnett post hoc analyses. Probability (P)
values of 0.05 or less were considered significant.
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